The story of D&M Pharma began in May 2003 in Santiago, Chile. A group of seasoned pharmaceutical executives pooled their industry expertise to build a lean, marketing-driven company designed to license and commercialize high-value therapies across the Southern Cone.
D&M Pharma Peru S.A.C. functions through five core product segments tailored for therapeutic and clinical fields. Its distribution portfolio includes several notable solutions: 1. Dermatological & Clinical Dermocosmetics
is an example of how a well-conceived business project, backed by strategic alliances and a firm commitment to quality, can prosper and add significant value to the healthcare system.
D&M Pharma Peru S.A.C. serves as a vital bridge between international pharmaceutical innovators and the local healthcare community. By acting as a local representative for foreign partners, the company eliminates the barriers to entry for international brands. This symbiotic relationship allows global manufacturers to tap into Peru’s growing market while providing Peruvian patients with access to cutting-edge therapies and generic alternatives. d amp m pharma peru sac
Un ejemplo documentado de esto es la Resolución Administrativa N.° 000439-2021-UAD-INSNSB, emitida por el gobierno peruano, que "" por un monto ascendente a S/.14,547.44 soles. Esta acción refleja la voluntad de la empresa de colaborar con las instituciones del estado para garantizar el acceso a tratamientos para los sectores más vulnerables.
D amp M Pharma Peru SAC is known to maintain sourcing agreements with suppliers from (e.g., Sun Pharma, Cipla copies), China (API and finished dosages), and local Peruvian manufacturers (such as Farmaindustria or Medifarma). These relationships allow the company to offer competitive pricing to price-sensitive buyers like regional government hospitals.
: Covers dermatology, respiratory, and biotechnology lines. The story of D&M Pharma began in May 2003 in Santiago, Chile
Delivering high-efficacy products for various dermatological needs.
If the company successfully secures more DIGEMID authorizations for advanced therapies (e.g., gene therapy vectors or monoclonal antibodies), it could ascend from a mid-tier wholesaler to a specialty logistics leader.
✅
(Desarrollos y Marketing Farmacéutico) is a leading pharmaceutical and medical wholesaler in Peru specializing in the commercialization, import, and distribution of high-quality dermatological, respiratory, and ophthalmological products . Founded on August 1, 2007 , the company serves as the Peruvian subsidiary of the regional D&M Pharma Group , which originally launched in Chile in 2003. By partnering with renowned global manufacturing companies—such as Argentina’s Laboratorio Cassará —D&M Pharma Peru S.A.C. bridges the gap between complex pharmaceutical developments and the localized healthcare needs of medical specialists and patients across Peru. Corporate Profile & Operational Core
: Biosol LC and various topical treatments for hair and skin health. Mission and Philosophy
Operating a dedicated risk-monitoring portal (farmacovigilancia@dympharmaperu.com) where patients and clinicians can report adverse events directly. Corporate Logistics and Information functions through five core product segments tailored for